Abstract
Four vacuolar type H(+)-ATPase (V-ATPase) inhibitors, i.e. concanamycin A (CMA), bafilomycin A1 (BMA), destruxin E (DRE) and prodigiosin 25-C (PRG) profoundly blocked the perforin-dependent cytotoxicity mediated by CD8+ CTL clone. Cytoplasmic acidic compartments were not detected under fluorescent microscopy after treatment of the cells with these V-ATPase inhibitors. In the lytic granule fractions, BMA, CMA, DRE and PRG completely abrogated the perforin activity, although these drugs slightly decreased the granzyme A activity. Under the same conditions, BMA and CMA markedly reduced the perforin content, while DRE and PRG had no significant effects as assayed by immunoblotting using anti-perforin antibody. These data suggest that perforin is predominantly inactivated even without proteolysis in DRE- or PRG-treated cells. We propose that acidic pH is essential to maintain not only quantity but also quality of perform in the lytic granules.
References
Jul 1, 1992·The Journal of Antibiotics·J T WooA Endo
Jun 5, 1992·Biochimica Et Biophysica Acta·S NaganumaA Endo
May 1, 1991·The Journal of Experimental Medicine·P J PetersH J Geuze
Dec 25, 1990·Biochemistry·D MassonJ Tschopp
Dec 1, 1990·The Journal of Cell Biology·J K BurkhardtY Argon
Jan 1, 1990·International Immunology·A KawasakiK Okumura
Jul 1, 1989·Physiological Reviews·M Forgac
Apr 18, 1985·Nature·U D StaerzM J Bevan
Jan 1, 1986·Annual Review of Biochemistry·I MellmanA Helenius
Aug 1, 1986·The Journal of Antibiotics·A NakamuraG Tamura
Nov 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·E J BowmanK Altendorf
Sep 1, 1987·Molecular Immunology·J Tschopp, D Masson
Aug 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·R G AndersonM S Brown
Aug 1, 1995·Bioscience, Biotechnology, and Biochemistry·M H LeeK Nagai
Dec 15, 1994·Biochemical and Biophysical Research Communications·M MuroiA Takatsuki
Feb 6, 1995·FEBS Letters·T KataokaK Nagai
Jun 1, 1993·Cell Structure and Function·M MuroiA Takatsuki
Apr 20, 1993·Biochemistry·S DröseK Altendorf
Oct 1, 1996·Bioscience, Biotechnology, and Biochemistry·T KataokaK Nagai
Oct 1, 1996·Bioscience, Biotechnology, and Biochemistry·T KataokaK Nagai
Citations
Jul 6, 2006·Applied Microbiology and Biotechnology·Yerra Koteswara RaoYew-Min Tzeng
Feb 28, 2002·Phytochemistry·M Soledade C PedrasDale E Ward
Mar 31, 2000·Immunology Today·F ButtgereitM D Brand
Sep 19, 2003·Bone·H NakagawaJ T Woo
Feb 26, 2000·Immunology·M H LeeK Nagai
Jan 15, 2003·Annals of the Rheumatic Diseases·A KuhnkeF Buttgereit
Jul 4, 2012·Arthritis Research & Therapy·Cornelia M SpiesFrank Buttgereit
Feb 6, 2014·The Journal of Antibiotics·Ryuichi SugamataKazuo Suzuki
Nov 29, 2007·Future Microbiology·Neil R WilliamsonGeorge P C Salmond
Jun 15, 2010·Molecular Immunology·Xiaoli FengChengyun Zheng
Nov 15, 2011·Biotechnology Advances·Bing-Lan Liu, Yew-Min Tzeng
Nov 28, 2012·Current Biology : CB·Lianne C DavisAntony Galione
Mar 27, 2001·Blood·A ItoY Kitamura
Sep 10, 2020·Proceedings of the National Academy of Sciences of the United States of America·Mark M PainterKathleen L Collins
Jan 16, 1999·The Journal of Biological Chemistry·S B PengD K Stone
Jul 10, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Shibani Mitra-KaushikMasanori Terajima
Jul 6, 2018·Cancer Immunology, Immunotherapy : CII·Ruben LacroixChristian U Blank
Nov 28, 2002·Clinical and Experimental Immunology·S YamadaK Agematsu
Oct 27, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jooeun BaeHans G Klingemann
Feb 6, 2002·Chembiochem : a European Journal of Chemical Biology·A FürstnerK Nagai
Nov 15, 2008·Journal of Medicinal Chemistry·Gersande LenaJulie A Spicer